Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets    
Cash, cash equivalents and restricted cash $ 132,542 $ 231,900
Short-term investments 286,210 234,178
Accounts receivable, net 20,401 15,414
Inventories, net 26,266 19,326
Prepaid expenses and other current assets 12,199 12,506
Total current assets 477,618 513,324
Non-current assets:    
Other non-current assets 11,838 11,838
Property and equipment, net 4,332 4,418
Acquired intellectual property and other intangible assets, net 7,882 8,404
Right-of-use assets 5,232 5,383
Total assets 506,902 543,367
Current liabilities    
Accounts payable and accrued liabilities 32,327 34,947
Other current liabilities 502 4,640
Operating lease liabilities 1,009 1,059
Total current liabilities 33,838 40,646
Non-current liabilities    
Deferred compensation and other non-current liabilities 17,379 15,950
Operating lease liabilities 7,562 7,680
Total liabilities 58,779 64,276
Commitments and contingencies (Note 18)
SHAREHOLDER’S EQUITY    
Common shares - no par value, unlimited shares authorized, 141,742 and 141,600 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively 1,178,807 1,177,051
Additional paid-in capital 64,686 59,014
Accumulated other comprehensive loss (1,618) (852)
Accumulated deficit (793,752) (756,122)
Total shareholders' equity 448,123 479,091
Total liabilities and shareholders’ equity $ 506,902 $ 543,367